Since you requested further information.
From JAT's announcment (https://www.asx.com.au/asxpdf/20200203/pdf/44ds5s7prnyzvt.pdf):
"Sales of the Neurio lactoferrin brands in January 2020 amounted to $3.44 million. This compares to sales of $407,000 in January 2019. In the six months ended 31 December 2019, sales of all Neurio products was $9.4 million."
So they did 37% of the previous 6 month's sales in just one month. Certainly a positive sign for A2M indeed.
2019-nCOV, page-204
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.81 |
Change
0.100(1.49%) |
Mkt cap ! $4.923B | |||
| Open | High | Low | Value | Volume |
| $6.72 | $6.84 | $6.70 | $10.26M | 1.513M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9090 | $6.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.81 | 17768 | 3 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |